Overview
Pablo Muxi practices in Montevideo, Uruguay. Mr. Muxi is rated as an Advanced expert by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Polycythemia Vera, Myeloproliferative Neoplasms (MPN), Essential Thrombocythemia, and Splenomegaly.
His clinical research consists of co-authoring 12 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Myeloproliferative Neoplasms (MPN).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Essential ThrombocythemiaMr. Muxi isAdvanced. Learn about Essential Thrombocythemia.
- MyelofibrosisMr. Muxi isAdvanced. Learn about Myelofibrosis.
- Myeloproliferative Neoplasms (MPN)
- Polycythemia VeraMr. Muxi isAdvanced. Learn about Polycythemia Vera.
- SplenomegalyMr. Muxi isAdvanced. Learn about Splenomegaly.
- Experienced
- Acute Myeloid Leukemia (AML)Mr. Muxi isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Promyelocytic LeukemiaMr. Muxi isExperienced. Learn about Acute Promyelocytic Leukemia.
- Blood ClotsMr. Muxi isExperienced. Learn about Blood Clots.
- Febrile NeutropeniaMr. Muxi isExperienced. Learn about Febrile Neutropenia.
- Hodgkin LymphomaMr. Muxi isExperienced. Learn about Hodgkin Lymphoma.
- LeukemiaMr. Muxi isExperienced. Learn about Leukemia.